Table 1. Study Participant Characteristics (n = 2804).
Characteristic | n | Percent | |
Age at entry (years Median (IQR)) | 40.2 | (34.1,46.4) | |
Sex | Female | 310 | 11 |
Male | 2494 | 89 | |
Race/Ethnicity | White | 1730 | 62 |
Hispanic | 490 | 17 | |
Black | 357 | 13 | |
Other/Unknown | 227 | 8 | |
HIV Risk Factor | MSM1 | 2180 | 78 |
IDU2 (not MSM) | 133 | 5 | |
Heterosexual (not IDU) | 367 | 13 | |
Other/Unknown | 122 | 4 | |
Baseline CD4 | <350/mm3 | 1230 | 44 |
≥350/mm3 | 1551 | 55 | |
missing | 23 | 1 | |
Baseline HIV viral load | ≤400 copies/mm3 | 1365 | 49 |
>400 copies/mm3 | 1412 | 50 | |
missing | 27 | 1 | |
On antiretroviral therapy | Yes | 2807 | 75 |
No | 707 | 25 | |
Smoking | Yes | 837 | 30 |
No | 1967 | 70 | |
Baseline cytology result3 | NAMC | 829 | 29 |
ASCUS | 919 | 33 | |
LSIL | 663 | 24 | |
ASC-H | 76 | 3 | |
HSIL | 317 | 11 | |
≥1 IRC4 after first cytology | Yes | 218 | 8 |
No | 2586 | 92 | |
No. cytology results/patient | Median (IQR) | 5 | (3,8) |
MSM: men having sex with men.
IDU: injection drug use.
NAMC: no atypical or malignant cells; ASCUS: atypical squamous cells of uncertain significance; LSIL: low grade squamous intraepithelial lesion; ASC-H: atypical squamous cells, can't exclude high grade; HSIL: high grade squamous intraepithelial lesion.
IRC: infrared coagulation.